There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today reported results for the quarter and year ended December 31, 2011. “I am pleased to report that Teva ended 2011 on a strong note, despite the challenges we faced during
Getty ImagesWatson's generic version of Lipitor helped to boost the company's fourth quarter earnings. Generic drugmaker Watson Pharmaceuticals said its profit surged in the fourth quarter as it began selling a low-cost version of the cholesterol drug Li
People walk past the Pfizer World headquarters in New York in this February 3, 2010 file photo. Pfizer Inc reported sharply lower quarterly earnings, hurt by generic forms of its Lipitor cholesterol drug, and the company trimmed its 2012 forecasts... View Photo »
Atorvastatin helps millions of Americans manage healthy cholesterol levels, and we are pleased to have received U.S. FDA approval to manufacture and market a safe, effective, affordable and accessible alternative to branded Lipitor
All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed. (AP) PARSIPPANY, N.J. Generic drugmaker Watson Pharmaceuticals Inc. said Tuesday its profit surged in the fourth quarter as it b
Abbott Laboratories shares have risen from a low a 12 month low of $45.07 set in August last year to now stand at $55, a fraction below their 52-week best of $56.84. Shares in the drugs giant remained little changed after fourth quarter results on Januar
Pfizer’s first earnings report after losing its exclusivity on Lipitor highlights some key concerns on what Big Pharma will do to mitigate the losses arising from the loss of patents for blockbuster drugs. Sales for Q4 2011 were $16.7 billion, a drop of
This Jan. 30, 2012 photo, shows boxes of the drug Relpax made by Pfizer, in Surfside, Fla. Pfizer Inc.'s fourth-quarter profit fell by half due to one-time charges and a drop in U.S. revenue, which was hurt by blockbuster cholesterol drug Lipitor losing... View Photo »
Lower bad cholesterol, higher good cholesterol, a little better effect on the arteries, but Lipitor was shown to be very close
Coumadin has been used since the 1950's for the prevention of clots, and has been the best selling oral anticoagulant for a number of years. First developed as a rat poison, Coumadin works by inhibiting vitamin K dependent clotting factors II, VII, IX, a
Maxxwell A.R. is a member of The Motley Fool Blog Network -- entries represent the personal opinions of our bloggers and are not formally edited. If you think Solazyme is a tough act to follow, then you certainly aren’t familiar with the next company in
Atorvastatin (INN) (pronounced /əˌtɔrvəˈstætən/), marketed under the trade name Lipitor and several other names worldwide, is a member of the drug class known as statins, used for lowering cholesterol. Atorvastatin inhibits the rate-determining enzyme located in hepatic tissue that produces mevalonate, a small molecule used in the synthesis of... Full Article
A prescription bottle of Lipitor(atorvastain calcium) tablets made by Pfizer and distributed by Parke-Davis is seen November 30, 2011 in Washington, DC. Pfizer's patent on the best-selling drug of all-time, the cholesterol-lowering medication Lipitor, expired on November 30, 2011,...
View Photo »People walk past the Pfizer World headquarters in New York in this February 3, 2010 file photo. Pfizer Inc reported sharply lower quarterly earnings, hurt by generic forms of its Lipitor cholesterol drug, and the company trimmed its 2012 forecasts because of negative effects of the...
View Photo »This Jan. 30, 2012 photo, shows boxes of the drug Relpax made by Pfizer, in Surfside, Fla. Pfizer Inc.'s fourth-quarter profit fell by half due to one-time charges and a drop in U.S. revenue, which was hurt by blockbuster cholesterol drug Lipitor losing patent protection. It still beat...
View Photo »In this Jan. 30, 2012 photo, a row of ChapStick containers is on display at a Mirmarar, Fla. drug store. Pfizer Inc. said Tuesday, Jan. 31, 2012, that its fourth-quarter profit fell by half due to one-time charges and a drop in U.S. revenue, which was hurt by blockbuster cholesterol...
View Photo »This undated photo provided by by Watson Pharmaceuticals Inc. , shows Atorvastatin Calcium tablets, or generic Lipitor, which is being sold under a deal with Pfizer. Cholesterol blockbuster Lipitor is so valuable to its maker that Pfizer Inc. is practically paying people to keep taking...
View Photo »In this Dec. 1, 2011 photo, Bruce Roth, Vice President of Discovery Chemistry at Genentech, is photographed on the Genentech campus in South San Francisco, Calif. Lipitor, the best-selling drug in the history of pharmaceuticals, is the blockbuster that almost wasn't. "There was a lot of...
View Photo »FILE - In this June 14, 2011 file photo, the drug Lipitor is displayed at Medco Health Solutions Inc. , in Willingboro, N.J. Cholesterol blockbuster Lipitor is so valuable to Pfizer Inc. that the drug giant is practically paying people to keep taking it after generic rivals hit the...
View Photo »FILE - In this June 14, 2011 file photo, the drug Lipitor is displayed at Medco Health Solutions Inc. , in Willingboro, N.J. Lipitor, the best-selling drug ever, was viewed as such an also-ran that it almost didn't make it into patient testing. But Lipitor reigned for nearly a decade as...
View Photo »This undated product image provided by AstraZeneca shows the pharmaceutical company's cholesterol drug Crestor. AstraZeneca PLC's big gamble, an attempt to prove its top-selling drug works better than rival cholesterol blockbuster Lipitor, appears to have backfired. A study meant to...
View Photo »In this June 14, 2011 photo, the asthma drug Singulair is displayed at Medco Health Solutions Inc. , in Willingboro, N.J. The cost of prescription medicines used by millions of people every day is about to plummet. The next 15 months will bring generic versions of seven of the world's...
View Photo »In this June 14, 2011 photo, various prescription drugs are displayed on the automated pharmacy assembly line at Medco Health Solutions Inc. , in Willingboro, N.J. The cost of prescription medicines used by millions of people every day is about to plummet. The next 15 months will...
View Photo »In this June 6, 2011 photo, Ray and Jo Kelly relax on a swing in front of their home in Conklin, Mich. , where they live in retirement. The two both take Lipitor and look forward to having extra money when the drug is replaced with a generic in the fall.
View Photo »A prescription bottle of Lipitor(atorvastain calcium) tablets made by Pfizer and distributed by Parke-Davis is seen November 30, 2011 in Washington, DC. Pfizer's patent on the best-selling drug of all-time, the cholesterol-lowering medication Lipitor, expired on November 30, 2011,...
View Photo »Lower bad cholesterol, higher good cholesterol, a little better effect on the arteries, but Lipitor was shown to be very close
It is a big deal, because Lipitor, which is now going to be generic, which makes it inexpensive, will make it much more accessible to people because now you've got a very potent statin at a much more affordable price.
They're all very effective in terms of lowering your cholesterol, but there's gradations in terms of the potency between the different statins. The two strongest statins are Lipitor and Crestor, and they're very close in terms of potency
We look forward to sharing our approach on how Medco's Lipitor strategy will save our clients and members upwards of $1 billion over the next year alone
Our strategy during the 180-day period is to help patients who want to stay on Lipitor have access to the brand after loss of exclusivity on November 30. Our programmes, which are designed to offer Lipitor at or below generic cost during the 180-day period, will not hike costs for significant number of ...
Our strategy during the 180-day period is to help patients who want to stay on Lipitor have access to the brand after loss of exclusivity on November 30. Our programmes, which are designed to offer Lipitor at or below generic cost during the 180-day period, will not hike costs for significant number of ...
Offering generic Lipitor® immediately at an everyday low price is another example of Walmart's commitment to helping our customers save money and live better, especially those who are struggling with the spiraling cost of health care in America and are often on a fixed income
We estimate $400 million sales during 180 days exclusivity based on 50 per cent price erosion and 30 per cent market share for Ranbaxy. The supply of Lipitor is from Ohm’s facility (in the US) that has high operating costs. Thus, assuming 65 per cent gross margin and 30 per cent profit share for Teva, w...
We estimate $400 million sales during 180 days exclusivity based on 50 per cent price erosion and 30 per cent market share for Ranbaxy. The supply of Lipitor is from Ohm’s facility (in the US) that has high operating costs. Thus, assuming 65 per cent gross margin and 30 per cent profit share for Teva, w...
Our intent is to offer Lipitor to payors and patients at or below the cost of a generic
We are concerned that the (benefits management companies) may charge health plan sponsors, including employers and Medicare Part D, full price for brand name Lipitor from Dec. 1, 2011 through May 31, 2012, while pocketing the discount from Pfizer
As a result, patients receive Lipitor at co-pays comparable to generics. Participation in Pfizer's programs by a health plan is entirely voluntary.
Atorvastatin helps millions of Americans manage healthy cholesterol levels and we are pleased to have received USFDA approval to manufacture and market a safe, effective, affordable and accessible alternative to branded Lipitor
It could well be that the Lipitor ingredients could come from Teva
While letters from PBMs to pharmacies indicate that a plan member’s co-pay for Lipitor would be discounted and equal to the cost of a generic prescription, we are concerned that the PBMs may charge health plan sponsors, including employers and Medicare Part D, full price for brand name Lipitor from Dece...
It’s not just the time on the market, it’s all the time in development. For a drug like Lipitor, it took about 6 to 7 years in clinical research before it was approved by the FDA so it really got about a 14 year patent life
You won’t see significant cost savings for Lipitor today. In six months, the price will drop significantly
We will probably never see another market success like Lipitor. In many ways the expiration of the patent marks an end to the blockbuster era of drugs ... We're now moving on to a future, one defined by targeted therapies and informed by an understanding of a patient's individual genetics, a future in w...
We will probably never see another market success like Lipitor. In many ways the expiration of the patent marks an end to the blockbuster era of drugs ... We're now moving on to a future, one defined by targeted therapies and informed by an understanding of a patient's individual genetics, a future in w...
The chemical makeup of the drug is the same ... So it will still lower your LDL cholesterol, still raise your HDL cholesterol to the same efficacy that it did when it was Lipitor.
When a second generic form of atorvastatin becomes available from another manufacturer, Lipitor will move to Tier 3, which generally has a co-pay of $30 to $50
Our intent is to offer Lipitor to payers and patients at or below the cost of the generic during the 180-day period.
UnitedHealthcare has placed Lipitor in a lower co-pay tier than the generic, because the brand name drug initially offers a lower net cost than generic atorvastatin
First-time generics, for the first several months after launch, can often cost the same or even more than the brand-name drug. UnitedHealthcare works diligently to keep down pharmacy costs for members and customers by providing the lowest net price, which is why we have placed Lipitor in the cheapest ti...
Ranbaxy Laboratories has gained approval to make generic atorvastatin calcium tablets (chemical name of Lipitor) in 10 milligram, 20 mg, 40 mg, and 80 mg strengths, US Food and Drug Administration (FDA) said in a statement. The drug will be manufactured by Ohm Laboratories in New Brunswick, New Jersey, ...
